Cargando…
Commentary:A prospective, randomized, parallel group, double blind, multicenter study to compare the efficacy, safety and immunogenicity of Lupin’s ranibizumab with lucentis in patients with neovascular age-related macular degeneration
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672751/ https://www.ncbi.nlm.nih.gov/pubmed/35918963 http://dx.doi.org/10.4103/ijo.IJO_753_22 |